Search Results - "Tvorogova, M G"

Macrophage-granulocyte colony-stimulating factor and fibroblast growth factor in the blood of patients with hyperlipoproteinemia by Saburova, O S, Tvorogova, M G, Soboleva, E L

“…Solid-phase ELISA revealed increased content of macrophage-granulocyte colony-stimulating factor and basic fibroblast growth factor in the serum of…”
Get full text

Results of assessing the quality of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum DNA by polymerase chain reaction in 2006-2007 by Tvorogova, M G, Gushchin, A E, Malakhov, V N

“…Analyzing the results of detection of C. trachomatis, M. hominis, and U. urealyticum DNA by the participants of the Federal External Quality Assessment System…”
Get more information

Lipids and lipoproteins. Laboratory diagnosis of lipid-transporting system disorders (a lecture) by Tvorogova, M G

Get more information

Quality of Neisseria gonorrhoeae DNA detection by polymerase chain reaction: the Federal External Quality Assessment System data by Tvorogova, M G, Malakhov, V N

“…An analysis of the data submitted in 2005 by 75 laboratories from 31 Russian Federation's regions, participated in the area of the Federal external quality…”
Get more information

Effect of therapy with atorvastatin on parameters of postprandial lipemia and factors of inflammation in patients with ischemic heart disease by Samoĭlenko, E Iu, Naumov, V G, Tvorogova, M G, Ezhov, M V, Sergienko, I V, Kukharchuk, V V

“…Reaction of parameters of lipid transport system to standard fat load (J.Patsch method), C-reactive protein (CRP) and fibrinogen levels were studied in 30…”
Get more information

Immunoreactivity of apolipoprotein B-100 and binding to LDL-receptor of phospholipase A2-treated low density lipoproteins by Korotaeva, A A, Golovanova, N K, Vlasik, T N, Yanushevskaya, E V, Tsibulsky, V P, Yakushkin, V V, Tvorogova, M G, Morozkin, A D, Prokazova, N V

“…Lipid--protein particles were obtained by treatment of low density lipoproteins (LDL) with phospholipase A2 from bee venom. Under these conditions, half of the…”
Get more information

The HRM-new molecular technique of detection of pharmaceutical resistance of micobacteria of tuberculosis by Lavrova, O I, Al'vares Figerova, M V, Tvorogova, M G

“…The early detection of isolates of mycobacterium of tuberculosis resistant to anti-tuberculosis pharmaceuticals is ultimately needed for optimization of…”
Get more information

Combination therapy with fluvastatin and fenofibrate in ischemic heart disease patients with combined hyperlipidemia and type 2 diabetes by Sarano, N E, Kozlov, S G, Tvorogova, M G, Liakishev, A A, Naumov, V G

“…To assess efficacy of combination therapy with fluvastatin and fenofibrate in ischemic heart disease (IHD) patients with combined hyperlipidemia and type 2…”
Get more information

Effektivnost' Amarila u bol'nykh sakharnym diabetom tipa 2, ozhireniem i arterial'noy gipertoniey by Mychka, V B, Tvorogova, M G, Chazova, I E

“…Сахарный диабет (СД) типа 2 представляет серьезную медицинскую и социальную проблему. Связан о это с чрезвычайно высокой распространенностью СД типа 2 и…”
Get full text

Effect of atorvastatin on endothelial function in patients with familial hypercholesterolemia by Balakhonova, T V, Pogorelova, O A, Susekov, A V, Kobylianskiĭ, A G, Kuznetsova, T V, Tvorogova, M G, Masenko, V P, Titov, V N, Kukharchuk, V V, At'kov, O Iu

“…To study the influence of treatment with HMG-CoA reductase inhibitor atorvastatin on endothelial function in patients with familial hypercholesterolemia type…”
Get more information

Effect of hormone replacement therapy on blood serum lipids in postmenopausal women with type 2 diabetes by Kozlov, S G, Dotsenko, Iu V, Sankova, A V, Liakishev, A A, Tvorogova, M G, Afanas'eva, O I, Titov, V N, Pokrovskiĭ, S N, Naumov, V G

“…There are limited data concerning influence of hormone replacement therapy (HRT) on lipid profile in women with type 2 diabetes. Aim of the study was to…”
Get more information

Otsenka effektivnosti, perenosimosti i bezopasnosti terapii fluvastatinom i fenofibratom u bol'nykh sakharnym diabetom tipa 2 so smeshannoy giperlipidemiey by Sarano, N E, Kozlov, S G, Lyakishev, A A, Tvorogova, M G, Naumenko, V G

“…Использование одного из гиполипидемических препаратов не позволяет добиться желаемого уровня показателей липидного профиля. У больных со смешанной…”
Get full text

Lipanor treatment of atherogenic hyperlipoproteinemia by Susekov, A V, Tvorogova, M G, Arabidze, G G, Kukharchuk, V V

“…The study of the hypolipidemic efficiency, safety and tolerance of ciprofibrate (lipanor) in therapy of atherogenic hyperlipoproteinemia. The trial included 14…”
Get more information

Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia by Tvorogova, M G, Susekov, A V, Semenova, O A, Kukharchuk, V V, Titov, V N

“…To reveal the metabolic parameters of lipoproteins (L), which determine the benefits of hypolipidemic effects of simvastatin (S) and fluvastatin (F); to trace…”
Get more information

PCR studies in laboratory diagnosis: problems of quality assurance by Tvorogova, M G, Gushchin, A E

“…The determination of DNA and RNA of causative agents by the nucleic acid amplification techniques (NAT) presented in the Russian laboratory diagnosis of…”
Get more information

Biochemical diagnosis of hereditary hyperlipoproteinemias by Tvorogova, M G, Rozhkova, T A, Alidzhanova, Kh G, Semenova, O A, Sobolev, A V, Kukharchuk, V V, Titov, V N

“…To specify characteristics of lipoproteins (LPs) metabolism in patients with diverse forms of hereditary hyperlipoproteinemia (HLP) and determine biochemical…”
Get more information

A comparison of the hypolipidemic action of probucol at doses of 500 and 1000 mg/day in moderate hyperlipoproteinemia by Tvorogova, M G, Lupanov, V P, Nuraliev, E Iu, Zaĭtseva, T M, Kukharchuk, V V, Titov, V N

“…Evaluation of effectiveness of hypolipidemic action of probucol in doses 500 and 1000 mg/day and comparison of probucol blood concentrations on the treatment…”
Get more information

Quality assessment of HCV RNA detection by PCR method in Federal System of External Quality Assessment in 2005 - 2007 by Tvorogova, M G, Chulanov, V P, Volkova, R A, Sudarikov, A B, Mikhaĭlov, M I, Isaeva, O V, Malakhov, V N

“…Part of the Federal System of External Quality Assessment of Clinical Laboratory Tests named "PCR-identification of hepatitis C virus (HCV)" and aimed at…”
Get more information

Apolipoprotein E in transport and receptor absorption of saturated fatty acids by cells; facts and hypothesis (literature review) by Titov, V N, Tvorogova, M G

Get more information

Biochemical studies in the diagnosis of acute pancreatitis by Tvorogova, M G, Titov, V N

Get more information